Can I read High-Dose IPV2 Vaccine Safety Study on EtoBox?

High-Dose IPV2 Vaccine Safety Study by api-102069217 is a document available to read on EtoBox.

What is High-Dose IPV2 Vaccine Safety Study about?

This randomized controlled trial compared the immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine (mIPV2HD) to standard trivalent inactivated poliovirus vaccine (IPV) in infants in Panama. The study found that 4 weeks after vaccination, seroconversion and antibody titers against poliovirus type 2 were significantly higher in infants receiving mIPV2HD compared to IPV. Both vaccines had similar safety profiles. The results support using mIPV2HD to provide improved p

Author

api-102069217

Language

EN